Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Approval crawled date : 2021 - 04 - 23 save search
ADC Therapeutics Announces FDA Approval of ZYNLONTA™ (loncastuximab tesirine-lpyl) in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Published: 2021-04-23 (Crawled : 23:00) - biospace.com/
ADCT | $4.85 -2.41% 170K
|
Health Technology
|
| O: 1.84%
H: 8.65%
C: -6.44%
fda fda approval approval t-cell
SmartFinancial Approves Regular Quarterly Cash Dividend
Published: 2021-04-23 (Crawled : 22:00) - globenewswire.com
SMBK | News | $21.055 4.18% 18K
|
Finance
| Email alert
Add to watchlist
approval
GW Pharmaceuticals Shareholders Approve Acquisition by Jazz Pharmaceuticals
Published: 2021-04-23 (Crawled : 21:00) - globenewswire.com
JAZZ | $108.08 -1.45% 220K
|
Health Technology
| Email alert
Add to watchlist
acquisition approval
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-04-23 (Crawled : 18:42) - fda.gov
LLY | News | $735.1 -1.42% 1.2M
|
Health Technology
| Email alert
Add to watchlist
RIGL | $1.12 -1.75% 400K
|
Health Technology
| Email alert
Add to watchlist
ILMN | $122.25 -1.78% 400K
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.825 -0.34% 9.7M
|
Health Technology
| Email alert
Add to watchlist
BGNE | $143.7 3.39% 120K
|
Health Technology
| Email alert
Add to watchlist
CLVS | $0.0812 -3.94%
|
Health Technology
| Email alert
Add to watchlist
KPTI | $1.095 0.46% 910K
|
Health Technology
| Email alert
Add to watchlist
ALNY | $144.31 -1.21% 200K
|
Health Technology
| Email alert
Add to watchlist
PFE | News 4 | $26.25 -0.27% 12M
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $168.21 -0.78% 1.2M
|
Health Technology
| Email alert
Add to watchlist
AGIO | $31.55 -0.82% 190K
|
Health Technology
| Email alert
Add to watchlist
VSTM | $9.515 -0.99% 40K
|
Health Technology
| Email alert
Add to watchlist
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
| Email alert
Add to watchlist
REGN | News | $909.39 0.23% 210K
|
Health Technology
| Email alert
Add to watchlist
AVEO | $15.0 0.0% 0
|
Health Technology
| Email alert
Add to watchlist
YMAB | $15.14 -1.3% 82K
|
Health Technology
| Email alert
Add to watchlist
BPMC | $93.1 0.88% 230K
|
Health Technology
| Email alert
Add to watchlist
EXEL | $23.74 1.93% 730K
|
Health Technology
| Email alert
Add to watchlist
ADCT | $4.85 -2.41% 170K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.765 -1.94% 950K
|
Health Technology
| Email alert
Add to watchlist
AMGN | News | $274.15 0.22% 900K
|
Health Technology
| Email alert
Add to watchlist
INCY | $51.76 0.21% 600K
|
Health Technology
| Email alert
Add to watchlist
cancer approval
FDA grants accelerated approval to loncastuximab tesirine-lpyl for large B-cell lymphoma
Published: 2021-04-23 (Crawled : 18:42) - fda.gov
ADCT | $4.85 -2.41% 170K
|
Health Technology
| Email alert
Add to watchlist
fda approval granted grant t-cell
European Commission Approves JEMPERLI (dostarlimab), the First Anti-PD-1 Therapy Approved for Recurrent or Advanced dMMR/MSI-H Endometrial Cancer in Europe
Published: 2021-04-23 (Crawled : 15:00) - globenewswire.com
ANAB | $18.83 -1.83% 99K
|
Health Technology
|
| O: 0.35%
H: 4.06%
C: 3.1%
europe therapy cancer trial approval dostarlimab
Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for Opdivo (nivolumab) Plus Yervoy (ipilimumab) as First-Line Treatment for Unresectable Malignant Pleural Mesothelioma
Published: 2021-04-23 (Crawled : 11:00) - biospace.com/
BMY | $48.825 -0.34% 9.7M
|
Health Technology
|
| O: -0.03%
H: 0.95%
C: -0.44%
treatment positive approval chmp nivolumab
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
CZOO | $10.52 110.82% 10M
|
CSSE 4 | $0.3181 108.86% 170M
|
Consumer Services
BOF | $1.88 60.68% 98M
|
AMST | $3.1 55.0% 66M
|
Technology Services
LICN | $0.85 51.79% 13M
|
WIMI | $1.03 41.99% 15M
|
Technology Services
SKIL 4 | $8.045 40.89% 230K
|
Information
MULN | News | $3.805 39.38% 11M
|
Information
RILY | $30.01 38.17% 11M
|
Finance
MTC | $3.04 35.71% 6.7M
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.